Literature DB >> 1365863

Effects of the 5-HT3 antagonist ondansetron on benzodiazepine-induced operant behavioural dependence in rats.

A J Goudie1, M J Leathley.   

Abstract

This study was designed to assess whether rats made tolerant to the suppressant action on Fixed Ratio operant responding of the benzodiazepine (BZ) chlordiazepoxide (CDP) would show behavioural disruption on drug withdrawal--so-called operant behavioural dependence. In addition, the study examined the effects of the 5-HT3 antagonist ondansetron on such operant behavioural dependence. During 42 consecutive days of CDP treatment, at doses escalated from 10 to 30 mg/kg/day, marked tolerance developed to the rate-suppressant action of CDP. On subsequent days, during spontaneous withdrawal, response rates declined significantly by around 30% in animals treated with saline, although some recovery of responding was seen over successive days of withdrawal. Similar reductions in responding followed by recovery were seen in rats treated with the 5-HT3 antagonist ondansetron (0.01-0.1 mg/kg, b.i.d.). These findings demonstrate for the first time that it is possible to use operant procedures to detect spontaneous BZ withdrawal. They also suggest, in agreement with recent studies from this laboratory (Leathley and Goudie 1992), that 5-HT3 antagonists may have relatively limited utility in treating some signs of BZ dependence.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1365863     DOI: 10.1007/bf02247724

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  30 in total

Review 1.  The psychopharmacology of 5-HT3 receptors.

Authors:  B Costall; R J Naylor; M B Tyers
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

Review 2.  Homeostatic theory of drug tolerance: a general model of physiological adaptation.

Authors:  C X Poulos; H Cappell
Journal:  Psychol Rev       Date:  1991-07       Impact factor: 8.934

3.  Operant behavior in the morphine-dependent rhesus monkey.

Authors:  S G Holtzman; J E Villarreal
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

Review 4.  Self administration of and behavioral dependence on drugs.

Authors:  C R Schuster; T Thompson
Journal:  Annu Rev Pharmacol       Date:  1969       Impact factor: 13.820

5.  Dependence on tetrahydrocannabinol in rhesus monkeys.

Authors:  P M Beardsley; R L Balster; L S Harris
Journal:  J Pharmacol Exp Ther       Date:  1986-11       Impact factor: 4.030

6.  Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal.

Authors:  G F Koob; T L Wall; F E Bloom
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Effects of cocaine administration and withdrawal on the performance of pigeons under a fixed-consecutive-number schedule with and without an external discriminative stimulus.

Authors:  R.D. Clark; A. Poling
Journal:  Behav Pharmacol       Date:  1990       Impact factor: 2.293

8.  Cocaine withdrawal produces behavioral disruptions in rats.

Authors:  M E Carroll; S T Lac
Journal:  Life Sci       Date:  1987-06-01       Impact factor: 5.037

Review 9.  Animal models of drug withdrawal symptoms.

Authors:  M W Emmett-Oglesby; D A Mathis; R T Moon; H Lal
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

10.  Disruption of schedule-controlled behavior by Ro 15-1788 one day after acute treatment with benzodiazepines.

Authors:  R D Spealman
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

View more
  4 in total

Review 1.  The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.

Authors:  A J Greenshaw; P H Silverstone
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

2.  Tolerance, cross-tolerance and dependence measured by operant responding in rats treated with triazolam via osmotic pumps.

Authors:  C Cohen; D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

Review 3.  Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications.

Authors:  M I Wilde; A Markham
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

4.  Effects of the CCKB antagonist L-365, 260 on benzodiazepine withdrawal-induced hypophagia in rats.

Authors:  A J Goudie; M J Leathley
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.